
CNS Brainstorm Episode 48 "Pediatric NF1 Therapeutics" with guest Bonnie Kaur, MD
Child Neurology Society's Brainstorm
00:00
MEK inhibitors mechanism explained
Bonnie Kaur describes selumetinib and mirdametinib as MEK inhibitors that block RAS-RAF-MEK-ERK signaling to stop tumor growth.
Play episode from 02:28
Transcript


